Primary dendritic cells phagocytose Cryptococcus neoformans via mannose receptors and Fcgamma receptor II for presentation to T lymphocytes - Wikidata - awgldk - TriplyDB

Primary dendritic cells phagocytose Cryptococcus neoformans via mannose receptors and Fcgamma receptor II for presentation to T lymphocytes

Primary dendritic cells phagocytose Cryptococcus neoformans via mannose receptors and Fcgamma receptor II for presentation to T lymphocytes

http://www.wikidata.org/entity/Q34182880

about

Surface glycans of Candida albicans and other pathogenic fungi: physiological roles, clinical uses, and experimental challenges.Cryptococcus and Phagocytes: Complex Interactions that Influence Disease Outcome Dancing cheek to cheek: Cryptococcus neoformans and phagocytes Host immunity to Cryptococcus neoformans Cryptococcal interactions with the host immune system.Extracellular vesicles from Cryptococcus neoformans modulate macrophage functions Stage-specific sampling by pattern recognition receptors during Candida albicans phagocytosis.Opsonic requirements for dendritic cell-mediated responses to Cryptococcus neoformans.Cryptococcus neoformans variants generated by phenotypic switching differ in virulence through effects on macrophage activation.Melanization of Cryptococcus neoformans affects lung inflammatory responses during cryptococcal infection.In vivo role of dendritic cells in a murine model of pulmonary cryptococcosis Recognition of the major cat allergen Fel d 1 through the cysteine-rich domain of the mannose receptor determines its allergenicity Dendritic cells and fungi.Cryptococcus neoformans-induced macrophage lysosome damage crucially contributes to fungal virulence.Toll-like receptors induce a phagocytic gene program through p38.Role of phagocytosis in the virulence of Cryptococcus neoformans.Modulation of the pulmonary type 2 T-cell response to Cryptococcus neoformans by intratracheal delivery of a tumor necrosis factor alpha-expressing adenoviral vector.The immune response to fungal infections.The Cnes2 locus on mouse chromosome 17 regulates host defense against cryptococcal infection through pleiotropic effects on host immunity The presence of capsule in Cryptococcus neoformans influences the gene expression profile in dendritic cells during interaction with the fungus.Role of the mannose receptor in a murine model of Cryptococcus neoformans infection CCR2 mediates conventional dendritic cell recruitment and the formation of bronchovascular mononuclear cell infiltrates in the lungs of mice infected with Cryptococcus neoformans.Role of dendritic cells and alveolar macrophages in regulating early host defense against pulmonary infection with Cryptococcus neoformans.The capsule of the fungal pathogen Cryptococcus neoformans.Antibodies generated against conserved antigens expressed by bacteria and allergen-bearing fungi suppress airway disease.Host defenses against cryptococcosis.Experimental models of cryptococcosis.Catch me if you can: phagocytosis and killing avoidance by Cryptococcus neoformans.Induction of protective immunity against cryptococcosis.Fungal surface and innate immune recognition of filamentous fungi.Capsular Material of Cryptococcus neoformans: Virulence and Much More.Immunity to Cryptococcus neoformans and C. gattii during cryptococcosis Role of capsule and interleukin-6 in long-term immune control of Cryptococcus neoformans infection by specifically activated human peripheral blood mononuclear cells.Role of dendritic cell-pathogen interactions in the immune response to pulmonary cryptococcal infection.Innate host defenses against Cryptococcus neoformans.Phagocytic activity and monocyte chemotactic protein expression by pulmonary macrophages in persistent pulmonary cryptococcosis.Spherules derived from Coccidioides posadasii promote human dendritic cell maturation and activation.Cryptococcus gattii Capsule Blocks Surface Recognition Required for Dendritic Cell Maturation Independent of Internalization and Antigen Processing.Mannoproteins from Cryptococcus neoformans promote dendritic cell maturation and activation.Innate Immune Responses to Cryptococcus.

P2860

Q24625384-B18D0A1E-88DE-48C8-99DB-497C7BD950AC Q26767978-D37EC387-2686-4EAE-ADE9-D075E3FA8FB2 Q26798926-8C38FD85-E53B-4F49-AFD3-96F96EAF9639 Q26823438-B210D04F-CC29-4F74-9F55-DD972F87D000 Q30387948-3C8FF3EF-3DE7-4079-BAA4-45856376B8D4 Q30493958-BC0E4C1C-305F-478A-9F0C-9A9ACC5E305F Q33388218-7A2F5866-C324-4009-B045-53FA0E5D3254 Q33559279-DFC6C6F3-E952-49CB-92FA-9E39B7C2BCCF Q33675737-4B71C9C3-A6D2-4702-A9BF-FB626C5E8382 Q33769483-6A3F8097-0694-4CD4-94C0-76043152EC65 Q34721052-AF4102F1-A319-4E29-8362-7A188D8D7F28 Q34787060-A7605B9A-9E30-4B44-A43B-9DF52C89C656 Q35219327-C837E221-DC00-49A8-9D0E-942D5C8E4B1B Q35231374-B80B8BF3-08D4-40B1-BB5C-77F22645859B Q35834699-89B425E7-8E3B-43FE-BE65-11E9CC55E7D3 Q35911335-B80E8C05-A8FA-4094-859A-28A502811B2C Q36097221-68FB581B-BB33-42FE-9D75-8EE96F7EDFAF Q36139489-D6B71FFD-6DAC-4D4F-B940-1E3E665E49CC Q36281331-90398E00-E962-4C6B-B38B-FA4A5AB8F1C3 Q36539579-DB9F3A87-2663-4059-93B2-20795C885F3D Q36710580-39802004-0194-4271-AE59-75594AB27E78 Q37326321-05E663A6-6B85-4AE6-ADD4-CED27FD1ED51 Q37333339-157F9837-8B8E-42F2-B4B3-E4F0D3CFAD16 Q37337879-1397D07F-FFAA-404A-A3E9-C52E33A153AB Q37478109-82617945-D1F6-4A4A-AA37-2AE73D290A9F Q37943849-E6BC8E06-092A-4E63-8F2A-9E016D55882F Q37946892-B4211BB8-113C-4253-93EE-A062FE515D1B Q37949657-FE11EC7C-DF7F-41C8-9451-D143A53E9611 Q37965038-E0DE54DB-8A56-424F-9A4F-6128F96370C8 Q37971025-41C34E4A-29C9-4D42-BE97-FE5A3A5617D7 Q37982326-F6F84296-DC53-427A-A31B-C90C0787100D Q38286732-9ADE0238-8BC3-4A88-BB52-EF15A5E7CD84 Q38482586-13C7D57B-0114-4B55-B199-DA34C0963405 Q38644509-C64FFC61-8B65-4BBA-9BBF-B860BA1BB6F8 Q38752388-247D43F2-73F9-4837-8410-D7D1E612B677 Q39714422-FD67BD53-6592-4CA5-81F9-508666A5D0DD Q40483346-1E408454-1119-4A1F-987C-78B4C0598C6E Q40842324-860F7A8C-A930-4765-9637-F637DDC2FD96 Q40995110-CC1CCBBB-3295-48CA-86E4-054EEA6FBC3C Q41721935-9B836CC8-E68C-40C5-A96B-A608BAC8C420

P2860

Primary dendritic cells phagocytose Cryptococcus neoformans via mannose receptors and Fcgamma receptor II for presentation to T lymphocytes

http://www.wikidata.org/entity/Q34182880

description

2002 nî lūn-bûn

@nan

2002 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

name

Primary dendritic cells phagoc ...... presentation to T lymphocytes

@ast

Primary dendritic cells phagoc ...... presentation to T lymphocytes

@en

Primary dendritic cells phagoc ...... presentation to T lymphocytes

@nl

type

label

Primary dendritic cells phagoc ...... presentation to T lymphocytes

@ast

Primary dendritic cells phagoc ...... presentation to T lymphocytes

@en

Primary dendritic cells phagoc ...... presentation to T lymphocytes

@nl

prefLabel

Primary dendritic cells phagoc ...... presentation to T lymphocytes

@ast

Primary dendritic cells phagoc ...... presentation to T lymphocytes

@en

Primary dendritic cells phagoc ...... presentation to T lymphocytes

@nl

P1433

Q34182880-C3182A15-E247-4A69-9F52-A484A46A31CB

P1476

Q34182880-24057E60-D2FF-41C5-8321-BB58A66A083D

P2093

Q34182880-07541318-C530-47D4-94D1-C88F18844B31

Q34182880-2F2E0B6E-B117-4D71-91EB-733FCC23F091

Q34182880-8777DDCB-8C4F-4D95-BF1B-64256CDB853C

Q34182880-D6847FE9-32E4-47BB-BAAC-65B7998E4418

P2860

Q34182880-021766CF-E86E-4334-BE00-B73E1BDD4DC7

Q34182880-0449C76C-D323-4083-89B8-243ABBDC60F8

Q34182880-04507349-AF65-45A3-831C-0031ADBD25AB

Q34182880-04951C60-C307-40D9-9235-CA8928D7A709

Q34182880-05624587-CB01-4132-A700-7B026227177B

Q34182880-099BA7F9-D86E-4FED-A8C4-9B9DA18E470B

Q34182880-0B08D1B9-F374-4AC6-AF8A-1ADFE80A6E7C

Q34182880-11533D13-C9FC-4B89-A758-A31534A8EAEF

Q34182880-12F163B2-832B-41D3-8C27-C4512D4EDC7D

Q34182880-14966011-F7A8-47C5-8882-A42485542A12

P304

Q34182880-BCE67C5F-08D3-4AB5-BDD8-D124CB713EA6

P31

Q34182880-78C0E758-06BD-4DA4-913B-459232E14BE0

P356

Q34182880-918EDCE8-6205-43CE-8C9A-9D67AB1FFEDA

P407

Q34182880-D647446C-8ED7-4691-B4A6-538C7CABF872

P433

Q34182880-02E71739-C8E5-4BAD-86BD-B526EA52369A

P478

Q34182880-8958248B-697C-4623-BDB5-81E7839AF555

P50

Q34182880-48D53285-2FC7-4871-BCFB-BE9143F43D05

P577

Q34182880-F46BBE7D-2B11-469D-ABCF-3EC0F1DB255A

P5875

Q34182880-82C30057-1F89-4927-80FD-0746F6E0D06B

P698

Q34182880-1E84B50D-EBBE-4E5B-88D0-ED7947673572

P932

Q34182880-051A9A8A-164D-4B39-B3E5-19743B2C0B77

P356

IAI.70.11.5972-5981.2002

P1433

Infection and Immunity

P1476

Primary dendritic cells phagoc ...... presentation to T lymphocytes

@en

P2093

Ernest K Amankwah

http://www.w3.org/2001/XMLSchema#string

Francis H Y Green

http://www.w3.org/2001/XMLSchema#string

Jason C L Spurrell

http://www.w3.org/2001/XMLSchema#string

Rachel M Syme

http://www.w3.org/2001/XMLSchema#string

P2860

Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products

Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha

Human T, B, natural killer, and dendritic cells arise from a common bone marrow progenitor cell subset

Candida albicans is phagocytosed, killed, and processed for antigen presentation by human dendritic cells.

Fc receptors for IgG and antigen presentation on MHC class I and class II molecules.

Transfer of immunity to cryptococcosis by T-enriched splenic lymphocytes from Cryptococcus neoformans-sensitized mice.

The cell wall and membrane of Cryptococcus neoformans possess a mitogen for human T lymphocytes.

The capsule of Cryptococcus neoformans reduces T-lymphocyte proliferation by reducing phagocytosis, which can be restored with anticapsular antibody

Phagocytosis and protein processing are required for presentation of Cryptococcus neoformans mitogen to T lymphocytes

Dendritic cells phagocytose and are activated by Treponema pallidum

P304

5972-5981

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/IAI.70.11.5972-5981.2002

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

70

http://www.w3.org/2001/XMLSchema#string

P50

Christopher H. Mody

P577

2002-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11080134

http://www.w3.org/2001/XMLSchema#string

P698

12379672

http://www.w3.org/2001/XMLSchema#string

P932

130340

http://www.w3.org/2001/XMLSchema#string